Showing results (4221-4230 of 6,973) with videos related to
Sort By:
Pageof 698
Histopathology|April 15, 2020
Impact on colorectal cancer pathology reporting practice of migration from TNM 5 to TNM 8Maurice B Loughrey, Olivia Kent, Michelle Moore, et al.Histopathology|April 19, 2020
Sry-related high-mobility-group/HMG box 10 (SOX10) as a sensitive marker for triple-negative breast cancerShirley K Jamidi, Jintao Hu, Chaiwat Aphivatanasiri, et al.Histopathology|April 9, 2020
SWI/SNF protein and claudin-4 expression in anaplastic carcinomas arising in mucinous tumours of the ovary and retroperitoneumKristine Chaudet, Marina Kem, Melinda Lerwill, et al.Histopathology|April 29, 2020
The clinicopathological and molecular analysis of gastric cancer with altered SMARCA4 expressionShih-Chiang Huang, Kwai-Fong Ng, Ta-Sen Yeh, et al.Histopathology|August 9, 2001
Cytoskeletal and kinetic epithelial differences between NSAID gastropathy and Helicobacter pylori gastritis: an immunohistochemical determinationG Y Lauwers, J Furman, L E Michael, et al.Histopathology|August 9, 2001
Tryptase-positive mast cells accompany lymphocytic as well as lymphoplasmacytic lymphoma infiltrates in bone marrow trephine biopsiesB S Wilkins, S L Buchan, J Webster, et al.Histopathology|August 9, 2001
CD10 and Bcl10 expression in diffuse large B-cell lymphoma: CD10 is a marker of improved prognosisK Ohshima, C Kawasaki, H Muta, et al.Histopathology|August 9, 2001
Endothelial nitric oxide synthase is strongly expressed in malignant mesothelioma but does not associate with vascular density or the expression of VEGF, FLK1 or FLT1Y Soini, A Puhakka, K Kahlos, et al.Histopathology|August 9, 2001
mRNA expression of urokinase and plasminogen activator inhibitor-1 in human crescentic glomerulonephritisH S Lee, S Y Park, K C Moon, et al.Histopathology|May 1, 1992
Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of diseaseS H SwerdlowPageof 698